PHAR - Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days

PR Newswire

LEIDEN, The Netherlands , March 30, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's Chief Executive Officer, Sijmen de Vries, and Chief Commercial Officer, Stephen Toor , will attend the Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days, April 3 - 4, 2023 in New York .

Pharming's CEO and CCO will take part in a fireside chat on April 3 at 15:20 ET / 21:20 CEST .

A live webcast and replay of the fireside chat can be found in the "Upcoming Events" and "News" sections of Pharming's website.

Pharming's CEO and CCO will be available for one-to-one investor meetings during the conference.

For more information about the conference, or to schedule a one-to-one with Pharming's management team, please contact your Guggenheim representative, or send an email to Pharming's Investor Relations team to investor@pharming.com .

About Pharming Group N.V.

Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands , and has employees around the globe who serve patients in over 30 markets in North America , Europe , the Middle East , Africa , and Asia-Pacific . For more information, visit www.pharming.com or follow us on LinkedIn .

Logo - https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg

SOURCE Pharming